Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Let's Talk About Our Feelings!!! -- Ignore unavailable to you. Want to Upgrade?

To: nihil who wrote (73470)	1/31/2000 11:24:00 PM
From: Ilaine	Respond to of 108807

There is some really exciting research being done with severed spinal cords - big bucks from big corporations. Regrowth of severed nerves is just getting interesting. Also very interesting new legislation to entice manufacturers to get into "orphan drugs", including extension of patents and tax subsidies. The "prizes" for new drugs are there. But as for cheap drugs for poor countries, I don't have good news. Saw something very intriguing the other day on a drug which inhibits colon cancer - a selective COX-2 inhibitor that went off-patent maybe 20 years ago. If you follow drugs at all, you'll recall that selective COX-2 inhibitors just got FDA approval last year - but now it seems to me that they were exciting because they could be patented. I'd love to start a drug company manufacturing orphan drugs.